Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma AUTHORS: ASSUNTA DE RIENZO, MICHAEL A. ARCHER, BEOW Y. YEAP, ET. AL ABSTRACT: Malignant pleural mesothelioma (MPM) is an aggressive cancer that occurs more frequently in men, but is associated with longer survival in women. Insight into the survival advantage of female patients may advance the […]
Cancer, Genetics, Mesothelioma, Oncology, Personalized Medicine, Pulmonology
Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma AUTHORS: ASSUNTA DE RIENZO, MICHAEL A. ARCHER, BEOW Y. YEAP, ET. AL A recent study by researchers at Brigham and Women’s Hospital and published in the Journal of Cancer Research explores gender differences in Mesothelioma. Different genetic mutations based upon mesothelioma subtypes may help explain the […]
Cancer, Genetics, Mesothelioma, Oncology, Personalized Medicine, Pulmonology
Sex bias in drug research: a call for change AUTHOR: Alyson J. McGragor In the March 2016 issue of The Pharmaceutical Journal, A Royal Pharmaceutical Publication, we again see a thoughtful article by Dr. Alyson J. McGregor, a founding board member of the Sex and Gender Women’s Health Collaborative. In the article, she makes the […]
Drug Doses, gender, Personalized Medicine, Pharmaceuticals, Pharmacology, sex, sex differences
